⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23130170 | 0.89 | — | — | |
| SCHEMBL17347829 | 0.89 | — | — | |
| SCHEMBL23837577 | 0.89 | MAPT (0.33) | — | |
| SCHEMBL23837392 | 0.87 | — | — | |
| SCHEMBL23837494 | 0.83 | — | — | |
| SCHEMBL17347695 | 0.82 | — | — | |
| SCHEMBL23130109 | 0.82 | — | — | |
| SCHEMBL23837395 | 0.80 | — | — | |
| SCHEMBL23129894 | 0.78 | — | — | |
| SCHEMBL17347802 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |